Comparison Table

Please rotate your device for details

  AmpliSeq for Illumina BRCA Panel TruSight Cancer
Key Use Germline and somatic analysis of BRCA1 and BRCA2. Germline mutation detection for common and rare cancers.
Design All exonic regions of the BRCA1 and BRCA2 tumor supressor genes and flanking intronic sequences. Fixed set of probes that enrich for 94 genes and 284 SNPs associated with common and rare cancers.
Library Prep Time 6 hours 12 hours
Genomic Content 22 kb 225 kb (94 genes, 284 SNPs)
Input Amount 10ng recommended 50ng gDNA
FFPE Compatible Yes No
Multiplexing Up to 96-plex Up to 96-plex
Method Amplicon  Enrichment
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see emea.illumina.com/company/legal.html.

© 2026 Illumina, Inc. All rights reserved.